Valuation: Vineet Laboratories Limited

Market Cap 56Cr 59.37L 53.25L 48.67L 44.43L 83.7L 86.34L 5.87Cr 2.34Cr 30Cr 2.23Cr 2.18Cr 94Cr P/E 2024
43.6x
P/E 2025 -1.42x
Enterprise Value 96Cr 1.02Cr 91.17L 83.32L 76.06L 1.43Cr 1.48Cr 10Cr 4Cr 51Cr 3.82Cr 3.73Cr 160.96Cr EV / Sales 2024
5,87,502x
EV / Sales 2025 8,90,202x
Free-Float
65.45%
Yield 2024 *
-
Yield 2025 -
27/10 Vineet Laboratories Limited Reports Earnings Results for the First Quarter Ended June 30, 2026 CI
25/08 Vineet Laboratories Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2026 CI
21/07 Vineet Laboratories Limited Announces Cessation of Gaddam Venkata Ramana to Hold the Office of Managing Director, Effective July 21, 2026 CI
29/05 Vineet Laboratories Limited Announces Resignation of Ramesh Kumar Bandari from Company Secretary and Compliance Officer and Ceases to Be Key Managerial Personnel, Effective May 29, 2026 CI
14/02 Vineet Laboratories Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2025 CI
07/02 Vineet Laboratories Limited Approves Appointment of Jasmin Kunal Tailor as Independent Director CI
17/12 Vineet Laboratories says rights issue price set at 30 rupees per share RE
27/11 Vineet Laboratories Gets Board Nod to Raise Up to INR300 Million via Rights Issue MT
27/11 Vineet Laboratories to raise funds up to 300 million rupees via rights issue RE
24/11 Vineet Laboratories to consider rights issue RE
08/11 Vineet Laboratories Limited Announces Resignation of Hari Priya Yerukalapudi as Independent Director, Effective November 08, 2025 CI
16/25/16 Vineet Laboratories Limited Approves the Appointment of Premananda Reddy Vennapusa as Non-Executive Director, Effective from September 15, 2025 CI
22/25/22 Vineet Laboratories Limited Reports Earnings Results for the First Quarter Ended June 30, 2025 CI
1 day+3.02%
1 week+5.74%
Current month+0.63%
1 month+4.55%
3 months+7.04%
6 months-2.78%
Current year+3.75%
1 week 35.64
Extreme 35.64
40.74
1 month 34.38
Extreme 34.38
41.3
Current year 27.96
Extreme 27.96
43.5
1 year 27.96
Extreme 27.96
47.39
3 years 26.51
Extreme 26.51
88.9
5 years 26.51
Extreme 26.51
92
10 years 26.51
Extreme 26.51
124
Manager TitleAgeSince
Director of Finance/CFO 76 01/01/2021
Human Resources Officer - -
Comptroller/Controller/Auditor - -
Director TitleAgeSince
Director/Board Member 57 10/11/2016
Director/Board Member 76 10/11/2016
Chairman 73 16/11/2020
Change 5-day change 1-year change 3-year change Capi.($)
+3.02%+5.74%-15.52%-28.20% 75.68L
-0.79%-4.48%+46.48%+125.69% 1,20600Cr
+1.43%+1.11%+48.05%+83.05% 66TCr
+1.07%-1.21%+32.92%+104.92% 51TCr
-0.36%-3.25%+45.42%+65.10% 38TCr
-0.14%-1.87%+70.06%+41.09% 36TCr
-0.78%-0.52%+30.47%+58.09% 31TCr
-0.80%-0.21%+7.98%+36.17% 29TCr
+0.03%-1.20%+43.79%+69.83% 25TCr
-0.41%-2.22%+40.43%+107.03% 21TCr
Average +0.23%-1.62%+35.01%+66.28% 41.8TCr
Weighted average by Cap. -0.04%-1.96%+42.71%+88.11%

Financials

2024 2025
Net sales 1.51T 16.06 14.4 13.16 12.02 22.64 23.35 158.67 63.27 805.51 60.28 58.99 2.54T 769.53 8.19 7.34 6.71 6.13 11.54 11.9 80.88 32.25 410.6 30.73 30.07 1.3T
Net income 1.03Cr 1L 98T 89.56T 81.76T 2L 2L 10.8L 4L 54.8L 4L 4L 1.73Cr -20Cr -21.48L -19.26L -17.61L -16.07L -30.28L -31.24L -2.12Cr -84.62L -11Cr -80.62L -78.89L -34Cr
Net Debt 44Cr 46.88L 42.05L 38.43L 35.08L 66.09L 68.18L 4.63Cr 1.85Cr 24Cr 1.76Cr 1.72Cr 74Cr 40Cr 42.28L 37.92L 34.65L 31.63L 59.6L 61.48L 4.18Cr 1.67Cr 21Cr 1.59Cr 1.55Cr 67Cr
Projected Income Statement - Annual - Vineet Laboratories Limited
Logo Vineet Laboratories Limited
Vineet Laboratories Limited is an India-based company engaged in the business of drug intermediates and bulk drugs. The Company specializes in pharmaceutical intermediates and fine chemicals. Its active pharmaceutical ingredient (API) intermediates products include Lopinavir, Ritonavir, Efavirenz, Nadolol, Glimepiride, Celecoxib, and Piroctone Olanine. Its fine chemicals and reagents include Isopropyl-beta-D-thiogalactopyranoside, 4-Nitrophenyl phosphate disodium salt, 5-Bromo-4-chloro-3-indolyl-beta-D-galactopyranoside (X-Gal), 5-Acetyl thiophene-2-carboxilic acid, n-Butyl Lithium, n-Butyl magnesium chloride, 3-Furaldehyde, 3-bromofuran, 1-methyl-imidazole-2-carboxaldehyde, 6-Aminouracil, Ethyldiazo acetate, and Phenylboronic acid. The Company also exports API intermediates, fine chemicals, and custom synthesis molecules.
Employees
57
Date Price Change Volume
08/26/08 ₹38.16 +3.02% 43,352
06/26/06 ₹37.04 -0.11% 2,22,856
05/26/05 ₹37.08 -1.25% 98,342
04/26/04 ₹37.55 +4.13% 53,360
03/26/03 ₹36.06 -0.08% 51,755
  1. Stock Market
  2. Stocks
  3. VINEETLAB Stock